Shantharam Harish
SEC insider (Form 3/4/5 filer). CIK 0001976391. Chief Financial Officer at ALX ONCOLOGY HOLDINGS INC (ALXO). 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 26, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Shantharam Harish has filed insider reports for
- ALX ONCOLOGY HOLDINGS INC (ALXO): Officer, Chief Financial Officer
Shantharam Harish
CIK: 0001976391
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALX ONCOLOGY HOLDINGS INC
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jan 26, 2026ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectStock option (right to buy)
303K shares- - Oct 14, 2025ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectEmployee Stock Option (right to buy)
198.8K shares- - Aug 18, 2025ALXO
ALX ONCOLOGY HOLDINGS INC
PurchaseDirect75K shares at avg. $0.78$58K - Apr 11, 2025ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectEmployee Stock Option (right to buy)
125K shares- - Jan 21, 2025ALXO
ALX ONCOLOGY HOLDINGS INC
AwardDirectEmployee Stock Option (right to buy)
600K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 26, 2026 | ALXO ALX ONCOLOGY HOLDINGS INC | Award Stock option (right to buy) | 303,000 | - | - | Direct |
| Oct 14, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | Award Employee Stock Option (right to buy) | 198,750 | - | - | Direct |
| Aug 18, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | Purchase | 75,000 | $0.78 | $58,402 | Direct |
| Apr 11, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | Award Employee Stock Option (right to buy) | 125,000 | - | - | Direct |
| Jan 21, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | Award Employee Stock Option (right to buy) | 600,000 | - | - | Direct |
1-5 of 5 transactions